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Manual annotation and categorization of non-standardized text (“free-text”) of drug orders 
entered into electronic health records is a labor-intensive task. However, standardization is 
required for drug order analyses and has implications for clinical decision support. Machine 
learning could help to speed up manual labeling efforts. The objective of this study was to 
analyze the performance of deep machine learning methods to annotate non-standardized text of 
drug order entries with their therapeutically active ingredients.
Materials & Methods
The data consisted of drug orders entered 8/2009-4/2014 into the electronic health records of 
inpatients at a large tertiary care academic medical center. We manually annotated the most 
frequent order entry patterns with the active ingredient they contain 
(e.g. “Prograf”←“Tacrolimus”). We heuristically included additional orders by means of 
character sequence comparisons to augment the training dataset. Finally, we trained and 
employed character-level recurrent deep neural networks to classify non-standardized text of 
drug order entries according to their active ingredients. 
Results
A total of 26,611 distinct order patterns were considered in our study, of which the top 7.6% 
(2,028) had been annotated with one of 558 distinct ingredients, leaving 24,583 unlabeled 
observations. Character-level recurrent deep neural networks achieved a Mean Reciprocal Rank 
(MRR) of 98% and outperformed the best representative baseline, a trigram-based Support 
Vector Machine, by 2 percentage points. 
Conclusion
Character-level recurrent deep neural networks can be used to map the active ingredient to non-
standardized text of drug order entries, outperforming other representative techniques. While 
machine learning might help to facilitate categorization tasks, still a considerable amount of 
manual labelling and reviewing work is required to train such systems.
BACKGROUND
Hospitals have been storing increasingly large amounts of electronic health record (EHR) data, 
including unstructured information such as non-standardized text, which in the clinical setting is 
sometimes referred to as “free-text”.1,2 Drug orders in particular hold considerable value for 
clinical decision support, prognostic modelling, inferring conditions and forecasting the risk for 
adverse events.3,4 To accomplish such downstream tasks, a standardized representation of drug 
order information is required. However, standardizing drug order information is a cumbersome 
and time-consuming manual effort, e.g. mapping the pharmaceutically active ingredient to the 
misspelled brand name as entered by the provider. Machine learning, natural language 
processing (NLP) and information retrieval methods have the potential to advance the manual 
process of making non-standardized text more accessible in clinical reasoning, for both humans 
and data-driven counterparts.5
Natural language processing for drug order information
Non-standardized text entries are an important part of general, as well as drug-related EHR 
documentation. However, the advantages of coded information in EHRs and the disadvantages of 
unstructured information are well-recognized and several studies have been published on NLP 
applications for non-standardized text.5 While the tasks addressed varied widely from study to 
study, numerous NLP tools were developed to extract drug information from clinical notes.6 
Many of these focused on dosage information such as the rule-based approach by Karystianis et 
al.7 The successful tool “MedEx” developed and published by Xu et al. used a semantic tagger in 
combination with a parser to extract drug names, administration routes, dose information and 
other features of drug orders.8
Further efforts were undertaken to apply NLP techniques to clinical text.9 In particular, 
researchers tend to concentrate on two variants of the same underlying task a) classifying an 
isolated stretch of text into one of several possible drug classes, or, b) recognizing named drug 
entities in longer consecutive stretches of text such as scholarly articles or electronic health 
records. Patrick and Li developed a hybrid machine-learned and rule-based system for drug 
information extraction from EHRs.10 Doan and Hu addressed the same task via a support vector 
machine with polynomial kernel and literal as well as syntactic and medical domain features, 
finding that rich manually crafted feature sets deliver the best performance results.11 Jiang et al. 
disambiguated clinical entities in hospital discharge summaries using a range of traditional NLP 
techniques and bag-of-words representations.9 Hussain and Qamar relied on tokenization and 
contextual information extraction derived from part-of-speech tagging and lexical operations for 
drug name matching followed by a term frequency-inverse document frequency (TF-IDF) 
ranking.12 While a wide range of vocabulary based information extraction schemes, e.g., based 
on resources such as the Unified Medical Language System (UMLS) have been proposed in the 
past, 13–15 more recent comparative studies find machine-learning-based models to perform better 
for this task.6 For this reason, our empirical performance comparison considered a recently 
described support vector machine baseline. In the following section we will discuss a range of 
more modern neural network-based approaches to medical text processing. 
Neural networks for medical text 
Artificial neural networks are inspired by the highly interconnected neurons of the animal brain 
and consist of groups (so-called layers) of nodes interconnected via mathematical activation 
functions. Given sufficiently many nodes and layers, these networks have the ability to 
approximate highly non-linear target functions and have been shown to excel at a wide range of 
tasks. An introduction into the topic can be found elsewhere.16 Recurrent neural networks 17 are 
able to process input sequences of arbitrary length while maintaining an internal representation 
of state. This property makes them highly suitable for speech recognition and natural language 
processing tasks. The Long Short-Term Memory (LSTM) module 18 has been especially 
effective by maintaining two latent state representations, distinguishing between a latent vector 
used in making predictions and another one used to encode sequential information in the module. 
This distinction is meant to allow for the representation of long-term dependencies across the 
input sequence. Unanue et al. used bi-directional LSTM-CRF models on word tokens for 
extraction of biomedical entities such as drug mentions.19 The Gated Recurrent Unit (GRU) 20 is 
a newer alternative RNN variant whose architecture resembles a simplified LSTM, striking a 
compromise between representation expressiveness and complexity. Gehrmann et al. presented a 
comparison of neural networks and more traditional natural language processing techniques for 
the task of patient phenotyping from clinical narratives, finding that the representation learning 
capabilities of neural network architectures can often outperform the more static behavior of 
systems relying on manually designed features.21
There are numerous examples of word-level RNNs based on part-of-speech tag embeddings 
corresponding to words or character-level embeddings in the literature.22,23 A token or word 
granularity enables the use of pre-trained embeddings, leveraging insights and resources from 
previous research efforts. However, this benefit comes at a cost. Computation is limited to a 
specific vocabulary and unable to process previously unseen words during the test or application 
phase, which has been referred to as an “out-of-vocabulary” issue. Character-level models have 
been successful at circumventing such effects.24,25 Lipton et al. applied LSTMs to perform multi-
label diagnosis classification, using irregularly sampled multivariate time series of clinical 
measurements.26 The success of this model family inspired some of the approaches presented in 
this article. Gridach proposed bi-directional LSTMs, on character-level embeddings for 
Biomedical Named Entity Recognition.27 Hasan et al. presented an attention-based bidirectional 
LSTM (alongside an encoder-decoder framework) to perform clinical paraphrasing with various 
applications such as search, summarization, and question answering.28 
To the best of our knowledge, and at the time of writing this article, there has been no prior study 
using pre-categorized, non-standardized text drug order entries to train RNN-based drug 
classification schemes. The objective of this study was to analyze the performance of deep 
machine learning methods to annotate non-standardized text of drug order entries with their 
therapeutically active ingredients.
MATERIALS AND METHODS
Description of dataset and pre-processing
The data was comprised of 26,611 unique, non-standardized text entries of drug order strings 
(referred to as “patterns”) collected 8/2009-4/2014 at the University Hospital Zurich, a large 
tertiary care academic medical center in Zurich, i.e. located in the German-speaking part of 
Switzerland. Drug order entries are almost exclusively German, as entered by the providers.
A typical entry is comprised of the brand name or active ingredient, often with information on 
the dosage, e.g. “Torasemid 10mg”. While some of these patterns, e.g. “Diamacron 60” 
(misspelled), were only observed once (i.e., only a single order used exactly this string), most of 
them re-occurred multiple times in the dataset. For instance, the string “Marcoumar 3mg” had 
been independently entered 17 times. We ordered all patterns descending by their frequency in 
the dataset and manually categorized the top 7.6% (2,028) by annotating them with one of 558 
distinct ingredients, leaving 24,583 unlabeled observations. The mean length of the drug order 
entries was 31.3 characters, an entry could be up to a maximum of 80 characters long, and the 
most frequent length across all patterns was 14 characters.
We used the Anatomical Therapeutic Chemical Classification System (ATC codes, WHO, 
Geneva, Switzerland; cf. https://www.whocc.no/) as source of drug ingredients. For instance, the 
non-standardized and slightly misspelled text “Amlodiipin 5mg” should be classified as a 
reference to the standardized ATC code C08CA01 for the active ingredient amlodipine, as the 
code is labelled in the ATC catalogue. For the classification task, we focused only on the non-
standardized text of the drug order as entered by the provider on the one hand, and on the other 
hand, corresponding ATC codes and their labels (ATC catalogue lists codes, and each code is 
labelled with the active ingredient). One active ingredients may have multiple valid ATC codes, 
e.g. vancomycin is usually administered intravenously (J01XA01), but in rare cases of oral 
administration of vancomycin for intestinal infections, the ATC code A07AA09 could be used. 
Nevertheless, we follow 10 in restricting our training dataset to exclusively consist of 
prescriptions with a single target in order to ensure a feasible task scope as well as accurate 
performance evaluation.
All drug order patterns were broken up into sequences of characters, making them the atomic 
tokens on which our method operates. We filtered out infrequent characters and replaced them 
with a designated “UNKNOWN” token. This step is a common practice in NLP to enable 
classifiers (neural networks as well as others) to process arbitrary sequences of text even if a 
particular token has never been encountered during model training.28 We applied “near-no-
filtering”, requiring a token to appear at least twice in the corpus or otherwise be replaced with a 
designated “UNKNOWN” token.
For the test set, we applied proportionate stratified random sampling, stratifying by ATC codes, 
with a sampling fraction of 0.25, ensuring that 25% of the examples of each ATC code were 
included in the test set. The test set was only comprised of observations from the original labeled 
data-set (i.e. not derived from any of the data augmentation steps described in the following 
section). In case the share of original labeled observations in the stratum was lower than 25% 
(this can be the case when most examples stemmed from the augmentation process described 
below), all original labeled observations of that label were reserved for testing.
Similarity-based classifier bootstrapping
Neural networks often rely on thousands or tens of thousands of tunable parameters. They have 
been shown to require large amounts of training data to accurately fit these parameters and 
thereby fully reach their potential predictive power.16 However, in our case, labeled data (2,028 
instances) was scarce, compared to an abundance of unlabeled examples (24,583 instances). We 
addressed this imbalance by means of a bootstrapping approach that propagated explicit labels to 
highly similar unlabeled instances before using both explicit as well as inferred labels for model 
training. To do so, we used a similarity measure, denoted , given by the Jaccard 𝑠𝑖𝑚( ⋅ , ⋅ )
similarity, , where  is a bag-of-words representation.𝐽𝑎𝑐𝑐𝑎𝑟𝑑(𝑋𝑖,𝑋𝑗) = |𝑋𝑖 ∩ 𝑋𝑗||𝑋𝑖 ∪ 𝑋𝑗| 𝑋𝑖
As a concrete example, the similarity between “Marcoumar” and “Marciumar”, a highly related 
pair of patterns is 0.8 while the similarity between “Marcoumar” and “Recormon” amounts to 
only 0.31. The similarity-based label-suggestion procedure for a given unlabeled observation  𝑋𝑗
and similarity threshold is described by the following steps:
● Compute the similarities  for all labeled observations .𝑠𝑖𝑚(𝑋𝑗,𝑋𝑖) 𝑋𝑖
● Retrieve a set of suggested labels and their corresponding similarities, such that the 
remaining similarities are above the given similarity threshold. The suggested label set is 
defined as: 𝑠𝑢𝑔𝑔𝑒𝑠𝑡𝑒𝑑(𝑋𝑗) = {(𝑌𝑖,𝑠𝑖𝑚(𝑋𝑗,𝑋𝑖))| 𝑠𝑖𝑚(𝑋𝑗,𝑋𝑖) ≥  𝑡ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑}
● Aggregate the set of distinct labels among the suggestions. The distinct label set of an 
input sequence is called unanimous if it contains exactly one label.𝑑𝑖𝑠𝑡𝑖𝑛𝑐𝑡(𝑋𝑗) = {𝑌𝑖| (𝑌𝑖, ⋅ ) ∈ 𝑠𝑢𝑔𝑔𝑒𝑠𝑡𝑒𝑑(𝑋𝑗)}
We evaluated similarity threshold values in the range [0.5, 0.85] using 0.05 increments and 
grouped all patterns in this score range into a discrete similarity bin (e.g., all patterns with 
similarity scores > 0.5 and <= 0.55 are associated to the same bin, patterns with scores > 0.55and 
<= 0.6 to the next, etc.). When choosing a high-similarity threshold, recall (sensitivity) is 
sacrificed for precision (positive predictive value [PPV]). In order to judge the quality of labels 
suggested by this procedure, a medical domain expert assessed their correctness on the basis of a 
sample of 100 suggestions. Within each similarity bin, suggestions were sampled at random. 
Since we expected the likelihood of error to be greater for low-similarity suggestions, we biased 
the sampling process to draw linearly more frequently from the low end of the similarity scale. 
Hence, we drew [19, 17, 16, 14, 13, 11, 10] observations from each bin, respectively.
Figure 1 plots the observed frequency of correct and incorrect suggestions as functions of the 
chosen similarity threshold. 
[|fig-suggestion-histogram|]
Figure 1: Bootstrap label propagation accuracy
We noted that similarity thresholds below 0.7 are highly error prone and should not be 
considered. It was, however, less clear how the proportions of false suggestions made in the 
[0.75, 0.8] and [0.7, 0.75] bins compare. They provided an interesting trade-off between label 
accuracy and breadth of coverage. As a consequence, we evaluated classifiers derived from 
various similarity thresholds of {0.7, 0.8, 0.9} and eventually also used a data-set without 
augmentation, which is equivalent to setting the similarity threshold to 1.0.
Proposed model variants
Recurrent Neural Networks are a neural network family that has been shown to be suitable for 
processing variable-length input sequences such as text data.18 These algorithms and their 
respective performances can vary considerably depending on input data representation, network 
structure, optimization procedures, or target cost function. This article investigates several 
network hyper-parameters, RNN cell architectures, data feed directions, input data 
representations, regularization schemes and optimization protocols. For input data representation, 
we evaluate both one-hot encoding (one distinct active bit per input sequence) and character-
level embeddings.29 In all settings, we rely on the popular Adam optimizer.30 The remainder of 
this section discusses the compared RNN types, data feed directions and regularization 
techniques.
Another aspect of the RNN architecture that needs to be considered is the manner in which data 
is parsed by the network. Traditionally, RNNs read their inputs sequentially, in a temporally or 
otherwise ordered fashion. Bidirectional RNNs, 31 can be applied to a finite sequence, by feeding 
inputs into an RNN at both the forwards and backwards direction. This procedure has been 
shown especially effective in sequence-to-sequence translation tasks and was included as an 
experimental parameter of our study.
To counter over-fitting effects, this study employed  norm regularization (weight decay), 𝐿2
dropout, 32 target replication 33 and noisy activation functions.34 Target replication, first 
introduced under the label of “companion loss”, makes the task of classifying entire sequences 
easier by replicating targets at every step. This study adopted a setup inspired by Lipton et al. 26 
having only one set of weights that are used both for output prediction and target replication 
prediction. Target replication is an especially promising choice in settings where input sequences 
vary as expected for different spellings of drug names. 
When applying target replication, an output  is generated at every sequence step. The 𝑦(𝑡)
resulting loss is a convex combination of the final loss (at step ) and the average of the losses 𝑇
over all steps, as defined in Equation 1, where  is a hyper-parameter that determines the 𝛼 ∈ [0,1]
relative importance of intermediary targets. At prediction time, only the final step’s output is 
considered.
𝛼 ⋅ 1𝑇 𝑇∑𝑡 = 1𝑙𝑜𝑠𝑠(𝑦(𝑡),𝑦(𝑡)) + (1 ‒ 𝛼) ⋅ 𝑙𝑜𝑠𝑠(𝑦(𝑇),𝑦(𝑇))
Equation 1: Loss Function
Finally, we experimented with adding noise to the non-linear activation function of a neural 
network, or “noisy activation”, to introduce linear behavior around the zero score range to allow 
gradients to flow easily when the unit is not saturated, while providing a definitive decision in 
the saturated regime. We followed the approach by Gülçehre et al. who postulate that the amount 
of noise added to the activation function should be proportional to the magnitude of saturation of 
the nonlinearity.34 Figure 2 demonstrates this behavior. 
[|fig-noisy-act-simulation|]
Figure 2: Noisy Activation
Evaluation procedure
Internally, each RNN model is evaluated using its cost function, multi-label cross-entropy.35 In 
general, RNNs should be evaluated based on the cost value, since training is aimed at 
minimizing that cost. However, when comparing different RNN models among each other to 
altogether different models, cost function values are not directly comparable. Instead, to allow 
for easy model comparison, we relied on Mean Reciprocal Rank (MRR) 36 as defined in 
Equation 2. The MRR metric is used in ranking scenarios with a single true class label. Instead 
of reporting accuracy measures at making a single guess, this metric lets the evaluated system 
produce a ranked list of all ATC codes in the sample, ordered by their likelihood of being 
referred to by the non-standardized input text. Optimal systems will rank the single true ATC 
code highly (i.e. at small numerical ranks ) in the output list. This results in a small 𝑟𝑎𝑛𝑘𝑖
enumerator component and a large overall MRR score. Overall MRR is reported as the average 
inverse rank across all test instances. The number of observations in both the training and test 
sets varies between experiments, from 606 and 177 training and test examples, respectively 
(without data augmentation), to 2,918 and 780 training and test examples, respectively, under 
consideration of a similarity threshold of 0.7. This metric is bounded in the [0,1] interval, where 
an MRR of 1 corresponds to perfect model performance.
𝑀𝑅𝑅 =‒ 1𝑛 𝑛∑𝑖 = 1 1𝑟𝑎𝑛𝑘𝑖
Equation 2: Mean Reciprocal Rank
To avoid inaccuracies in labels derived from using the similarity bootstrapping procedure, the 
test set is comprised exclusively of observations from the manually labeled data-set for which 
there is no doubt as to the ground truth. As a baseline comparison, we included a support vector 
machine (SVM), with n-gram and bag-of-words features and preprocessing as described above.
Due to the considerable number of tunable model hyper parameters (see appendix), we determine 
the optimal hyper parameter settings for each model type via 10-fold cross-validation on the 
training set. Only once this model-specific optimal configuration is found, is the trained model 
evaluated a single time on the held-out test set. The results of this test set evaluation will be 
discussed in the following section.
RESULTS
Our study compares two RNN architectures (GRU, LSTM), two data feeding directions (feed-
forward, bidirectional) and four similarity-based bootstrapping methods (similarity thresholds of 
0.7, 0.8, 0.9, 1.0), resulting in a total of  n=2*2*4=16 separately trained model variants. The 
results are shown in Figure 3. We can note that all compared methods achieved very high 
performance levels that lie consistently above the MRR = 0.95 mark.  
We see that, across all conditions, GRU architectures outperformed all other models. While the 
bidirectional GRU architecture’s performance was roughly stable across different similarity 
thresholds, the feed-forward models performed worse as the similarity threshold decreased and 
more noisy training examples were included. While the GRUs were clearly leading the 
performance comparison, the remaining methods (SVM and LSTM) were difficult to distinguish 
from each other, showing very similar performance scores and only local variances depending on 
bootstrapping similarity thresholds. 
With only few local exceptions, feed-forward architectures appeared superior to bidirectional 
methods. Only in case of high levels of training data noise induced by low bootstrapping 
similarity thresholds, did bidirectional processing offer advantages.
We can note that the choice of similarity threshold for training data augmentation had only a 
limited effect on the resulting models’ performance. Somewhat surprisingly, it was the SVMs 
rather than the highly parametric neural networks that benefitted most strongly from the 
availability of additional noisy training examples. The LSTM models showed a non-monotonic 
development of MRR scores in response to relaxed similarity thresholds, experiencing a local 
performance minimum for similarity thresholds of 0.8 from which they recover in both 
directions. While this augmentation method holds an interesting potential for training different 
model types (e.g., SVMs vs. neural networks), the overall highest scores are obtained via models 
trained exclusively on noise-free manually labeled examples.
[|figure-rnn-svm-performance|]
Figure 3: Global method performance
Aside from these fundamental architectural decisions, we investigated a broad range of 
hyperparameters including embedding hidden-state sizes, noisy activation, dropout and target 
replication parameters. While we observed locally effective combinations, the only general trend 
that could be noted was a beneficial effect of noisy tanh activation over other activation 
functions. The 16 models presented above are the individually strongest configurations per 
architecture. Their complete range of hyperparameters is described in the appendix.
Seeing how all compared methods achieve similar performance scores, we conducted a second, 
alternative performance evaluation in a more challenging setting. Going beyond the previous 
global performance evaluation, we broke down results per input prescription sequence length, as 
shown in Figure 4. The longest individual drug order name was 80 characters long (a hard 
limitation imposed on this field by the medical center’s clinical information system). In this 
experiment, we restricted the input data that the classifiers receive to only the first k characters, 
, making it harder for the classifiers to correctly identify the intended ATC code. 𝑘 ∈ {1, ..., 80}
The models were identical to the previously discussed ones and were not specifically retrained 
for this more challenging setting. As expected, all models perform better given larger choices of 
k (i.e., longer input sequence to classify). The extent of this performance detriment, however, 
varies considerably across model types and data augmentation thresholds. After as few as five 
processed characters, the feed-forward GRU-based method achieved close-to-optimal 
performance at recognizing active agents from drug orders. For all other methods, this level of 
accuracy was reached after having processed approximately 50-70 characters. As the amount of 
training set noise induced by similarity-based bootstrapping was increased, the number of 
characters necessary to attain a given performance level increased for all methods. While 
generally not performing well on short input sequences, again, SVMs show good robustness to 
noisy training labels. 
[|figure-MRR-per-length|]
Figure 4: MRR as a function of input sequence length.
DISCUSSION AND CONCLUSION
This study investigated the use of character-level RNN classifiers for automatically categorizing 
non-standardized text drug orders into groups of ATC codes representing the active ingredients. 
Our experiments identified an array of neural network architectures that surpassed the quality of 
more traditional text classification methods such as regression or support vector models.
In comparison with other approaches, Korkontzelos et al. considered DrugBank entries as a 
dictionary in their investigation.37 They suggested a boosting approach to increase the number of 
annotated drugs, in a way similar to the bootstrapping used in the present study to annotate 
further unlabeled drug orders. However, we did not additionally rely on external resources such 
as DrugBank.
The sophisticated work by Li et al. used machine learning and NLP in a hybrid algorithm to 
perform medication reconciliation.38 This research group analyzed clinical non-standardized text 
notes and matched identified drugs with their structured drug order counterparts to detect 
discrepancies. Although they did not apply recurrent neural networks, the involvement of drug 
order data shows some parallels to our present study.
Still, the use of deep neural networks in “drug name recognition” has been advocated.39 
Chalapathy et al. investigated recurrent neural architectures to recognize drug name mentions in 
non-standardized text.40
In summary, to our knowledge, it appears that our study is the first to use recurrent neural 
networks to categorize non-standardized text drug order entries into groups of active ingredients 
based on the ATC classification. Since our approach is independent of clinical notes, it could be 
applied on-the-fly, immediately during computerized provider order entry (CPOE).
Our study has limitations that need to be taken into account in interpreting the results. We used 
drug ordering data from a single center and only inpatient data were available. While our method 
achieved high accuracy, coverage remains a concern. In order to be able to assign a given ATC 
code, the deep learning system requires at least one manually created training example of a non-
standardized text order for this active agent. Considering the broad range of available ATC 
codes, this implies a considerable manual labeling effort in order to arrive at a system that 
delivers not only high accuracy but also satisfying coverage of the common drug order spectrum. 
In this work, we limited manual labelling to the 7.6% most frequently observed drug order 
sequences, and in a bootstrapping effort propagated explicit labels to similar unlabeled data 
points. With the bootstrapping effort, we were able to retrieve additional variations of previously 
scarcely observed drug order character sequences. This increase in variation enabled us to train 
our classifiers on these previously rare ATC codes, thus improving the coverage of known ATC 
codes. However, this does not remedy limited coverage across all drug orders.
This study has implications for EHR-driven healthcare processes and research in domains such 
as clinical decision support or automated adverse drug reaction identification in cases of non-
standardized text drug order entry, but also for administrative tasks, e.g. billing and auditing 
purposes that require considerable manual involvement, as parts of the electronically available 
data are non-standardized and cannot be automatically processed a priori. The proposed methods 
are therefore approaches to reduce the manual burden needed for the extraction of categorical 
information from non-standardized text input.
Additionally, from a computer science and NLP perspective, the present study investigated how 
limiting the number of available characters of a non-standardized text drug order may influence a 
reliable recognition of the correct active agent, and we found that highly accurate predictions can 
be made already very early in the input sequence. This observation holds considerable potential 
towards creating smart input assistance for clinical information systems that allow clinical staff 
to efficiently document drug orders by typing only few characters, while not limiting them to a 
fixed list of exact drug name spellings. Such technology combines the benefits of flexible, highly 
expressive non-standardized text input and easily interpretable and auditable categorical drug 
orders, which can be seen as a more tolerant interpretation of the drug order entered. However, 
there is still a downside to this approach, which leads to opportunities for future research as 
suggested below.
It is well known that look-alike, sound-alike drug names are sometimes confused by providers, 
which is a serious threat to patient safety.41 Lists of drug and brand names requiring particular 
caution have therefore been put forward as a strategy to mitigate the risk of ordering the wrong 
therapy.42 On the one hand, some approaches described here could help to generate lists of 
similar drug and brand names that should be investigated in terms of the usefulness of 
automatically extending lists of drug names prone to erroneous ordering. On the other hand, it is 
likely that “automated tolerant interpretation” of order entries as mentioned above may increase 
the risk of misinterpretation and confusion. Hence, there is room for human factors and NLP 
research to develop approaches reducing the risks arising from look-alike, sound-alike drug and 
brand names. Therefore, further research is needed around the “human-in-the-loop” model by 
investigating questions of trust, acceptance, re-traceability and thus ultimately explainability of 
the results.43
To address one of the method’s current limitations, namely low coverage, we suggest drawing 
from external resources such as UMLS, Drugbank or Wikipedia in order to obtain a broad, yet 
accurate overview of drug identifiers. This approach holds the additional benefit of creating a 
bridge between different national languages. While non-standardized text drug orders for the 
same active agent may differ vastly based on language and local branding, structured knowledge 
repositories typically provide pointers to various language variants of the same entity. Still, these 
datasets often contain very limited amounts of textual variance per drug, due to their structured 
and normalized nature. Therefore, in order to effectively train a supervised learning model, it is 
better to compose a dataset from different sources. This would enable achieving a sufficient level 
of textual variance, necessary for supervised learning. 
In conclusion, character-level recurrent deep neural networks can be used to map the active 
ingredient to non-standardized text of drug order entries, outperforming other representative 
techniques. While machine learning might help to facilitate categorization tasks, still a 
considerable amount of manual labelling and reviewing work is required to train such systems. 
In order to reduce the manual annotation burden per project, there is significant promise in using 
semi-supervised learning or weak/distant supervision techniques that leverage existing labels 
from other, related tasks when training new models. This direction should be carefully 
investigated in future work. The ultimate goal of the proposed approach for the clinical practice 
would be the “on the fly interpretation” of non-standardized text of drug order entries in order to 
warn the provider against harm potentially induced by the drug. For instance, “penicilin” [sic] 
could – although misspelled – still trigger an anaphylactic shock if administered to a patient with 
a penicillin allergy. 
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Highlights
 We automatically annotated non-standardized text of drug orders with their active 
ingredients
 The study focused on character-level recurrent deep neural networks
 The proposed method achieved a Mean Reciprocal Rank of 98% and outperformed a 
range of representative alternatives
Summary points
What is already known?
 Drug orders hold considerable value for clinical decision support, prognostic modelling, 
inferring conditions and forecasting the risk of adverse events
 However, non-standardized text order entries are a well-known problem hampering the 
automated interpretation of electronically ordered drug therapies
What does this study add?
 We automatically annotated non-standardized text of drug orders with their active 
ingredients by means of character-level recurrent deep neural networks
 The proposed method achieved a Mean Reciprocal Rank of 98% and outperformed a 
range of representative alternatives
 While machine learning might help to facilitate categorization tasks, still a considerable 
amount of manual labelling and reviewing work is required to train such systems
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RNN cell architecture LSTM, GRU
Data feed direction forward-feed, bidirectional
Data vector representation 4 dimensional character-level embeddings,
8 dimensional character-level embeddings,
one-hot character-level encoding
Learning rate 10-3, 10-2, 10-1, dynamically changing
Optimization protocol ADAM optimizer, Stochastic Gradient 
Descent
Hidden state dimensionality 16, 32, 64, 128
 norm regularization weight𝐿2 10-3, 10-2, 10-1
Target replication regularization weight 0.3, 0.5
Dropout keep probability 0.5, 0.7, 1.0
Activation function Tanh, Noisy tanh
P (noisy activation function parameter) Learn, 1.0
Alpha (noisy activation function parameter) 0.9, 1.15
Noise (noisy activation function parameter) Normal, Half-normal


























1 GRU F 0.9810
Noisy 
tanh
F 0.9 T 0.01 1 128 0.01 0.3
2 GRU F 0.9801
Noisy 
tanh
T 1.15 T 0.01 0.5 128 0.001 0.5
3 GRU F 0.9795
Noisy 
tanh
F 1.15 F 0.01 0.5 128 0.01 0.5
4 GRU F 0.9795
Noisy 
tanh
F 0.9 T 0.01 0.5 128 0.01 0.5
5 GRU F 0.9790
Noisy 
tanh
T 1.15 F 0.01 0.7 128 0.01 0.3
6 GRU F 0.9789 Tanh NA NA NA 0.01 0.7 128 0.001 0.5
7 GRU F 0.9777
Noisy 
tanh
T 0.9 F 0.01 0.5 128 0.01 0.5
8 GRU T 0.9774
Noisy 
tanh
T 1.15 T 0.01 0.5 128 0.001 0.5
9 GRU F 0.9769
Noisy 
tanh
T 1.15 F 0.01 0.5 128 0.001 0.5
10 GRU F 0.9768
Noisy 
tanh


























1 GRU F 0.9810
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tanh
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tanh
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tanh
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tanh
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tanh
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1 GRU T 0.9764
Noisy 
tanh
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tanh
T 0.9 T 0.01 0.5 128 0.001 0.5
3 GRU F 0.9762
Noisy 
tanh
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tanh
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tanh
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MRR per prescription length
